VC-backed Tempest Therapeutics recruits Laport as chief medical officer
Tempest Therapeutics Inc, a biotech company, has named Dr. Ginna Laport as chief medical officer. Previously, she was vice president of clinical development at Corvus Pharmaceuticals. Also, Tempest has promoted Dr. Alicia Levey to chief business officer. Tempest’s backers include Versant Ventures, F-Prime Capital, Quan Capital, Lilly Asia Ventures, Foresite Capital and Eight Roads Ventures.
4 September 2018•3 mins read
